Drag a card by its title · ⚙ to size, swap or remove

The company

Anixa Biosciences, Inc.

ANIX · Nasdaq

Health CareBiotechnologyNot moving yet

ANIX stood above a rising 150-day average in 10 of the last 52 weekly readings, and has been out of that trend for the last 7 weeks. It is 8.4% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 7
Industry in uptrend: 18% -12 in 4 wk
Insider buys, 12 months: $942K
Insider sales, 12 months: $0
Officials’ trades on record: 0
Institutions holding: 62 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 10 of 52 weeks.

22 Apr – 21 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months19

Sale orders, 12 months0

Buyers · sellers4 · 0

Who	Did	Shares	Traded
Amit KumarChief Executive Officer	bought	8,000at $2.72	22 Oct 2026filed 22 Oct 2026
Michael CatelaniPresident, COO, & CFO	bought	5,500at $2.84	30 Sep 2026filed 30 Sep 2026
Arnold M. BaskiesDirector	bought	5,000at $2.76	24 Sep 2026filed 28 Sep 2026
Amit KumarChief Executive Officer	bought	7,000at $2.78	24 Sep 2026filed 28 Sep 2026
Lewis H. Titterton, Jr.Director	bought	49,036at $2.69	23 Sep 2026filed 25 Sep 2026
Amit KumarChief Executive Officer	bought	5,000at $2.76	10 Sep 2026filed 11 Sep 2026
Lewis H. Titterton, Jr.Director	bought	10,000at $2.73	10 Sep 2026filed 14 Sep 2026
Amit KumarChief Executive Officer	bought	3,000at $2.75	10 Sep 2026filed 14 Sep 2026
Amit KumarChief Executive Officer	bought	5,000at $3.47	31 Jul 2026filed 3 Aug 2026
Amit KumarChief Executive Officer	bought	3,188at $3.37	27 Jul 2026filed 27 Jul 2026
Amit KumarChief Executive Officer	bought	5,000at $3.44	27 Jul 2026filed 28 Jul 2026
Amit KumarChief Executive Officer	bought	3,000at $3.73	24 Jul 2026filed 27 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders62+4 on the quarter

New · exited12 · 8

Reported value$14.7M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,329,852$3.7M	+14,870+1.1%
UBS Group AGadded · filed 13 Aug 2026	585,430$1.6M	+33,793+6.1%
Laird Norton Wetherby Trust Company, LLCadded · filed 14 Aug 2026	578,727$1.6M	+12,400+2.2%
D.A. DAVIDSON & CO.unchanged · filed 24 Jul 2026	539,272$1.5M	00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026	359,194$1.0M	-5,537−1.5%
MARSHALL WACE, LLPadded · filed 13 Aug 2026	328,332$919K	+155,153+89.6%
BlackRock, Inc.added · filed 7 Aug 2026	199,755$559K	+29,652+17.4%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026	192,356$539K	+1,282+0.7%
STATE STREET CORPunchanged · filed 7 Aug 2026	159,040$445K	00.0%
LPL Financial LLCadded · filed 7 Aug 2026	111,535$312K	+30,559+37.7%